Cortellis Product Intelligence
Your trusted source to build a more resilient supply chain
Make timely and data-driven business decisions with a comprehensive, single source of market performance, patent and manufacturing data.
- Track 85k+ companies, including API and dose manufacturers, across the global supply chain.
- Access 26k+ SPCs to map exclusivity timelines and support market entry planning.
- Analyze sales and volume data for 63k+ molecules to forecast demand and sourcing needs.
- Explore 1.4m+ patents, SPCs, and litigation records to uncover IP risks and opportunities.
Request more information
Optimize global pricing and market access with confidence
Strengthen your pricing strategy with global reimbursement and pricing trends for final dose formulations in 90+ markets. Access up to 5 years of historical market share and reimbursement data for the US and LATAM to anticipate payer pressure and support informed portfolio decisions.

Why business development, portfolio, IP, and sourcing experts trust CPI
Accurately forecast loss of exclusivity
Identify generic entry timing with insights from 26k+ SPCs and 1.4m+ patents, including litigation and exclusivity data.
Drive informed launch planning
Plan smarter with global data on 85k+ companies and 63k+ molecules, supported by sales, pricing, and market share trends.
Gain insight into biopharma pricing dynamics
Understand pricing and reimbursement trends with access to robust historical data and 18.5k+ synthesis schemes.
Never miss a launch window with timely LOE intelligence
Pinpoint the earliest generic entry dates by analyzing patents and exclusivities. Uncover new launch opportunities with 50+ criteria on LOE and market potential, supported by timely patent, manufacturing, and performance updates—all in one trusted solution.
